
Sign up to save your podcasts
Or


In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!
By Bernard Marini, Anthony Perissinotti, et al.4.5
3030 ratings
In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!

38,482 Listeners

26,040 Listeners

88,023 Listeners

113,446 Listeners

56,951 Listeners

187 Listeners

10,331 Listeners

7,237 Listeners

53 Listeners

8 Listeners

16,543 Listeners

10,983 Listeners

51 Listeners

196 Listeners

737 Listeners